Suitors Weigh Bids for Sanofi's $3B European Generics Biz Post author:Sam Post published:January 10, 2018 Post category:BioPharma The portfolio consists of acute, chronic and oncology products. Source: BioSpace You Might Also Like Axovant CEO David Hung Abruptly Exits, COO and Several Directors Also Resign February 11, 2018 Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks October 10, 2017 Theranos CEO Gives Up Own Shares to Investors to Avoid Being Sued March 23, 2017
